LY3437943 is the development code for retatrutide. Registry titles often put the code in parentheses because development programs may use both the code and the generic name.
One molecule, two search names
A development code identifies the molecule in the study record. Trial IDs identify individual protocols. Searching the code can surface registrations missed by a search that uses only the generic name.
How to interpret the evidence
In a registry record, look at the intervention, population and comparator together. The same molecule can be studied in different populations under different protocols.
Start with the intervention name and receptor targets, then follow the links to the original trial if you want to check what was measured in people.